Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Gross Profit: 2011-2024

Historic Gross Profit for Agios Pharmaceuticals (AGIO) over the last 13 years, with Dec 2024 value amounting to $32.3 million.

  • Agios Pharmaceuticals' Gross Profit rose 36.91% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.1 million, marking a year-over-year increase of 32.96%. This contributed to the annual value of $32.3 million for FY2024, which is 35.05% up from last year.
  • Agios Pharmaceuticals' Gross Profit amounted to $32.3 million in FY2024, which was up 35.05% from $23.9 million recorded in FY2023.
  • Agios Pharmaceuticals' Gross Profit's 5-year high stood at $32.3 million during FY2024, with a 5-year trough of $6.6 million in FY2021.
  • Over the past 3 years, Agios Pharmaceuticals' median Gross Profit value was $23.9 million (recorded in 2023), while the average stood at $22.9 million.
  • Data for Agios Pharmaceuticals' Gross Profit shows a peak YoY spiked of 90.99% (in 2023) over the last 5 years.
  • Over the past 4 years, Agios Pharmaceuticals' Gross Profit (Yearly) stood at $6.6 million in 2021, then skyrocketed by 88.82% to $12.5 million in 2022, then spiked by 90.99% to $23.9 million in 2023, then skyrocketed by 35.05% to $32.3 million in 2024.